The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business models driven by AI were all topics at a panel… Read More
Inside the headquarters of Outpace Bio in Seattle, senior scientist Bobby Langan shows a video of one of his favorite deep learning tools. A fuzzy blob coalesces into a molecular… Read More
Vancouver, Wash.-based drug design and development company Absci laid off employees Tuesday, a little more than a year after going public. “The macro-economic conditions of the last few months prompted… Read More
Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in an IPO that valued the biotech company at nearly $2… Read More
Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a public company. Absci priced its stock at $16 per share… Read More
Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built… Read More